
Musings on Supply Chain & Logistics for Cell Therapies
June 13, 2022 1:59 pm Leave your thoughtsWhere the Cell Therapy industry is facing an ever-growing complexity in supply chain and logistics, now is the time to... View Article
Where the Cell Therapy industry is facing an ever-growing complexity in supply chain and logistics, now is the time to... View Article
Raw material experts Dr. David Wellis and Dr. Robert Tressler want to share their knowledge on how to select and... View Article
Next-level characterization of donor immune cells can be used as a foundation for promoting high patient response rates. Last week... View Article
Donors play an important role in how well patients respond to immunotherapy, making donor characterization a critical success factor. Chimeric... View Article
Scientists at the H. Lee Moffitt Cancer Center in Florida are investigating the potential for using tumor infiltrating lymphocytes in... View Article
Scientists at GSK in Waltham, Massachusetts, are using Excellos-sourced T cell starting material for their preclinical evaluation of an anti-PD1... View Article
The launch of Excellos now brings scientific and cell manipulation expertise to support the development of investigational cellular products through to commercialization, by leveraging the San Diego Blood Bank (SDBB) and its network of collection centers.
T cell immunotherapy is a promising and relatively new field of medicine focused on tailoring a person’s own immune cells... View Article
Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank San... View Article